Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Multicellular muscle-tendon bioprinting of mechanically optimized musculoskeletal bioactuators with enhanced force transmission

Filippi M., Mock D., Fuentes J., Y Michelis M., Balciunaite A., Paniagua P.

Animal Study on Tendon Injury, published in Sci Adv (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sci Adv (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40668913
PMCID
PMC12266124
DOI
10.1126/sciadv.adv2628
Citations
4

Abstract (original English)

Biohybrid actuators leveraging living muscle tissue offer the potential to replicate natural motion for biomedical and robotic applications. However, challenges such as limited force output and inefficient force transfer at tissue interfaces persist. The myotendinous junction, a specialized interface connecting muscle to the tendon, plays a critical role in efficient force transmission for movement. Engineering muscle-tendon units in vitro is essential for replicating native musculoskeletal functions in biohybrid actuators. Here, we present a three-dimensionally bioprinted system integrating skeletal muscle tissue with tendon-mimicking anchors containing fibroblasts, forming a biomimetic interdigitated myotendinous junction. Using computational models, we optimized muscle geometries to enhance deformation and force generation. The engineered system improved mechanical stability, myofiber maturation, and force transmission, generating contractile forces of up to 350 micronewtons over a 3-month period. This work highlights how biomimetic designs and mechanical optimization can advance bioactuator technologies for applications in medicine and robotics.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Muscle, SkeletalTendonsAnimalsHumansTissue EngineeringBiomimeticsRoboticsBioprintingBiomechanical PhenomenaPrinting, Three-Dimensional

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research